May 5, 2026
Where Science Meets Justice: Before Most of Us Wake Up, TAG is Already Defending HIV Progress
Treatment Action Group’s (TAG) HIV team works across the country to achieve a shared mission: end the HIV epidemic through science, policy, and advocacy. As a remote team, the reach is national but the urgency is personal. At a time when progress is possible and precarious, the team ensures that…
April 23, 2026
The Path Forward: TAG’s Vision for HIV, TB, and Hepatitis C
TAG’s leadership and staff broke down the latest in HIV, TB, and hepatitis C research and advocacy. See where the work stands and where it’s headed.
April 15, 2026
TAG Statement on Results of the PreVenTB Phase III Trial of TB Vaccine Candidates VPM1002 and Immuvac
Statement / Press
Well-conducted study sponsored by Indian Council of Medical Research did not meet primary efficacy endpoint of preventing microbiologically confirmed TB disease
April 8, 2026
The CDC’s Unjustified Halt on Testing for Dangerous Pathogens is Bad for Everyone’s Health – TAG Calls for CDC to Immediately Reinstate Essential Diagnostic Testing
Statement / Press
CDC pauses rabies, mpox, and other infectious disease testing amid budget cuts and staffing losses, raising urgent public health concerns.
April 7, 2026
TAG Public Comments for the AIDS Research Advisory Council (ARAC) Meeting, April 6, 2026: Renewing Funding for the HIV Clinical Trial Networks
Letter / Comment
TAG recommends that the AIDS Research Advisory Council (ARAC) endorse NIAID’s continued support of a balanced and comprehensive portfolio of basic, clinical, and implementation science — including a funding opportunity to renew its four current networks: the Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections (ACTG), the International Maternal…
April 3, 2026
Near Point-of-Care TB Tests: What Communities Need to Know and Advocate for in Global Fund Grant Cycle 8
Publication
TB testing is getting faster, cheaper, and more accessible and advocates have a critical window to act. Treatment Action Group’s new factsheet breaks down WHO-recommended near point-of-care TB tests and shows how communities can use Global Fund Grant Cycle 8 to finance their rollout. With an estimated 2.7 million people…
March 24, 2026
Job Posting: Administrator
We’re seeking a highly organized and technically proficient Administrator to support the organization as it continues to grow. This position reports to TAG’s Director of Finance. This is a full-time, salaried role.
March 24, 2026
World Tuberculosis Day 2026
On World TB Day, TAG is excited to share our most recent TB vaccine materials: a new TB vax-zine, community partnership report on emerging vaccines, supply chain analysis of adjuvants that boost vaccine effectiveness, and the most recent pipeline report on TB vaccines in development.
March 19, 2026
What TB Treatment Advocates Need to Know about aDSM/PV
Webinar / Presentation
Join TAG on April 16 at 8:30 a.m. ET for a practical webinar on drug safety monitoring in TB treatment. Learn how to identify side effects, support patient safety, and understand pharmacovigilance in the context of newer, all-oral DR-TB regimens.
March 18, 2026
TAG Condemns Latest U.S. “Forever” War in the Middle East, Calls for Reprogramming Billions from Military Aggression to Health and Research
Statement / Press
TAG condemns the United States’ war in Iran and neighboring countries. At a time when U.S. investment in public health is being slashed, the Trump administration has chosen to spend billions of dollars per day on weapons used in a war of choice for which no credible rationale has been…
March 12, 2026
2026 CROI Tuberculosis Research Round Up
Statement / Press
New tuberculosis research presented at the 2026 Conference on Retroviruses and Opportunistic Infections (CROI) in Denver offers important updates on TB prevention and treatment for people living with HIV. TAG summarizes key findings on short-course preventive therapy, treatment dosing strategies, and emerging long-acting technologies. Read TAG’s analysis.
February 17, 2026
Internship Opportunity: Research Intern, TB Project
We are seeking a Research Intern to support our work advancing innovative financing strategies to accelerate tuberculosis (TB) research, development, and equitable access to lifesaving tools. In collaboration with the Senior TB Project Associate, the Research Intern will develop a research proposal and conduct research related to the relationship between…
February 10, 2026
Job Posting: Grant Officer
We’re seeking a dynamic, highly motivated, and organized Grant Officer to lead TAG’s grant work and support fundraising efforts. Candidates should be grant professionals with a background in domestic and global public health research, practice, and advocacy, focused on expanding and maintaining TAG’s current grant portfolio. This is a full-time,…
January 20, 2026
What Could Go Right? Vital Partnerships with Communities and Civil Society for New Tuberculosis Vaccines
Publication
What Could Go Right: Vital Partnerships with Communities and Civil Society for New Tuberculosis Vaccines, written together with community partners and supported by Wellcome, explores the indispensable role of communities and civil society in preparing the way for new TB vaccines and ensuring their success once they become available.
January 13, 2026
What Could Go Right? Partnering with Communities and Civil Society for New TB Vaccines
Webinar / Presentation
New tuberculosis (TB) vaccines could be realized as soon as 2028 — radically reshaping the journey to eliminate TB. Communities and civil society organizations are poised to play a vital role in the introduction of a future TB vaccine as central protagonists of this next chapter for TB elimination.